Form 4: CVRx CHRO Gregory Morrison Granted Equity

CVRx, Inc.'s Chief Human Resources Officer, Gregory Morrison, was granted 34,000 restricted stock units and 154,500 stock options on March 2, 2026.

Summary

• Gregory Morrison, Chief Human Resources Officer of CVRx, Inc., acquired 34,000 shares of common stock in the form of restricted stock units (RSUs) on March 2, 2026.
• These RSUs vest as to 25% of the shares on each annual anniversary of the grant date.
• Morrison also acquired 154,500 stock options with an exercise price of $8.22 per share on March 2, 2026.
• The stock options vest as to 25% on March 2, 2027, and as to 1/48th of the shares each month thereafter, with an expiration date of March 1, 2036.
• Following these transactions, Morrison beneficially owns 34,000 shares of common stock and 154,500 stock options.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with long-term company performance and shareholder value.

Positives

• The grant of restricted stock units and stock options aligns the Chief Human Resources Officer's interests with long-term shareholder value.
• Equity compensation serves as a retention mechanism for key management personnel.

Future Outlook

This filing does not contain forward-looking statements or guidance beyond the vesting schedules of the granted equity.

Industry Context

StockSavvy.ai notes that equity grants to executive officers, such as this one to the Chief Human Resources Officer, are a standard practice across industries, particularly in the medical device and biotechnology sectors where CVRx operates. These grants are designed to incentivize long-term performance and align executive interests with shareholder returns, a common strategy for talent retention and motivation in competitive markets.

Comparison to Industry Standards

• StockSavvy.ai observes that the structure of this equity grant, involving both restricted stock units (RSUs) and stock options with multi-year vesting schedules, is consistent with typical executive compensation packages in the medical technology industry.
• Companies like Medtronic (MDT) and Boston Scientific (BSX) frequently utilize similar long-term incentive plans for their executives, often tying a significant portion of compensation to equity performance.
• The 25% annual vesting for RSUs and a combination of initial 25% vesting followed by monthly vesting for options are common mechanisms to ensure executive retention and sustained performance over several years, mirroring practices seen in comparable firms.

Related Party Transactions

• The equity grant to Gregory Morrison, an executive officer, constitutes a related party transaction, as it involves compensation from the company to a key management personnel.

Stakeholder Impact

• Shareholders: The grant aligns executive incentives with shareholder interests, potentially leading to better long-term performance. However, it also represents potential future dilution upon vesting and exercise.
• Employees: This grant to a senior executive may signal stability in the leadership team and a commitment to long-term incentives.

Next Steps

• The restricted stock units will vest as to 25% of the shares on each annual anniversary of the grant date (March 2, 2026).
• The stock options will vest as to 25% of the shares on March 2, 2027, and as to 1/48th of the shares each month thereafter.
• The stock options will expire on March 1, 2036.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to an executive officer, which is a standard component of executive compensation. While it aligns management incentives with shareholder interests, it does not present new information that would fundamentally alter the company's valuation or immediate investment thesis. Therefore, a "hold" recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific compensation event.

Keywords

CVRx, CVRX, Gregory Morrison, Chief Human Resources Officer, CHRO, SEC Form 4, insider transaction, restricted stock units, RSUs, stock options, equity compensation, beneficial ownership